Literature DB >> 18705767

Sebaceous carcinoma of the eyelids: thirty cases from Japan.

Miki Izumi1, Kiyoshi Mukai, Takeshi Nagai, Jun Matsubayashi, Keiichi Iwaya, Cheng-Sheng Chiu, Hiroshi Goto.   

Abstract

Sebaceous carcinoma of the eyelids is rare in Western countries but not uncommon in Asian countries. Diagnosis is difficult both clinically and histologically. Thirty cases of sebaceous carcinoma of the eyelids treated at Tokyo Medical University Hospital were reviewed to elicit characteristic features of pathological findings. The tumor cells were infiltrating in a lobular pattern that consisted mainly of large atypical germinative cells. Sebocytes seen in the lobules had conspicuous nucleolus associated with perinucleolar halo. In 17 cases (57%) there was foamy histiocyte infiltration in and around the tumor nests. Sebaceous duct differentiation, namely holocrine secretion indicating a specific type of coagulation necrosis maintaining a cellular framework or maintaining a bubbly cytoplasm associated with nuclear debris in the periphery, was seen in 24 cases (80%). Although unequivocal squamous differentiation was limited to only 11 carcinomas, scattered individual necrosis with nuclear debris in the background of germinative cells appeared in 29 cases (96.7%). Expression of epithelial membrane antigen, perilipin and adipophilin were detected in all cases. In conclusion, to detect sebaceous differentiation in sebaceous carcinoma, it would be helpful to focus on holocrine secretion, squamous differentiation and foamy macrophage infiltration, and to utilize immunohistochemistry involving anti-perilipin and anti-adipophilin stain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18705767     DOI: 10.1111/j.1440-1827.2008.02260.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  9 in total

Review 1.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

2.  Sebaceous cell carcinoma of the eyelid: a rapidly enlarging lesion with massive xanthogranulomatous inflammation.

Authors:  Frank S Hwang; Aneesh Neekhra; Mark J Lucarelli; Thomas F Warner; Stephen N Snow; Daniel M Albert
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2010 May-Jun       Impact factor: 1.746

3.  My journey into the world of salivary gland sebaceous neoplasms.

Authors:  Douglas R Gnepp
Journal:  Head Neck Pathol       Date:  2012-03-20

Review 4.  Sentinel lymph node biopsy for eyelid and conjunctival tumors: what is the evidence?

Authors:  Pia R Mendoza; Hans E Grossniklaus
Journal:  Int Ophthalmol Clin       Date:  2015

5.  Primary sebaceous carcinoma of the tongue.

Authors:  Hisashi Oshiro; Toshinori Iwai; Makoto Hirota; Kenji Mitsudo; Iwai Tohnai; Ryogo Minamimoto; Motoko Omura-Minamisawa; Yoji Nagashima; Shoji Yamanaka; Takafumi Fukui; Michiyo Kanazawa; Hiromi Sagawa; Kazuhiro Mita; Takashi Nakayama; Yoshiaki Inayama
Journal:  Med Mol Morphol       Date:  2011-01-26       Impact factor: 2.309

6.  Sebaceous carcinoma arising from sebaceoma.

Authors:  Da Woon Lee; Si Hyun Kwak; Jun Hyuk Kim; Je Yeon Byeon; Hyun Joo Lee; Hwan Jun Choi
Journal:  Arch Craniofac Surg       Date:  2021-04-29

7.  A case of orbital sebaceous gland carcinoma developing in an anophthalmic socket 65 years after enucleation.

Authors:  Motoko Shibata; Yoshihiko Usui; Shunichiro Ueda; Hajime Matsumura; Toshitaka Nagao; Hiroshi Goto
Journal:  Clin Ophthalmol       Date:  2013-09-16

8.  Simulators of squamous cell carcinoma of the skin: diagnostic challenges on small biopsies and clinicopathological correlation.

Authors:  Kong-Bing Tan; Sze-Hwa Tan; Derrick Chen-Wee Aw; Huma Jaffar; Thiam-Chye Lim; Shu-Jin Lee; Yoke-Sun Lee
Journal:  J Skin Cancer       Date:  2013-06-25

9.  c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis.

Authors:  Denny L Cottle; Kai Kretzschmar; Pawel J Schweiger; Sven R Quist; Harald P Gollnick; Ken Natsuga; Satoru Aoyagi; Fiona M Watt
Journal:  Cell Rep       Date:  2013-02-09       Impact factor: 9.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.